Down-regulation of miR-21 Induces Differentiation of Chemoresistant Colon Cancer Cells and Enhances Susceptibility to Therapeutic Regimens.

MicroRNAs are endogenous posttranscriptional modulators that negatively control the expression of their target genes and play an important role in the development and progression of many malignancies, including colorectal carcinoma. In particular, expression of microRNA-21 (miR-21) is greatly increased in chemotherapy-resistant (CR) colon cancer cells that are enriched in undifferentiated cancer stem/stem-like cells (CSCs/CSLCs). We hypothesize that miR-21 plays a critical role in regulating differentiation of CR colon cancer cells. Indeed, we observed that downregulation of miR-21 in CR colon cancer cells (HCT-116 or HT-29) by antisense miR-21 induced differentiation, as evidenced by marked increases in cytokeratin-20 (CK-20) expression and alkaline phosphatase activity. These changes were accompanied by a significant reduction in the expression of colon CSC/CSLC marker CD44, colonosphere formation, and T-cell factor/lymphoid enhancer factor (TCF/LEF) activity but increased the expression of proapoptotic programmed cell death 4 gene. Induction of differentiation greatly increased sensitivity of CR colon cancer cells to the growth inhibitory properties of all three regimens tested: 5-fluorouracil + oxaliplatin (FUOX), difluorinated curcumin (CDF), and the combination of CDF and FUOX. However, the magnitude of inhibition of growth by either CDF (75%) alone or CDF + FUOX (80%) was much higher than that observed with only FUOX (40%). Growth inhibition by CDF and CDF + FUOX in differentiating CR colon cancer cells was associated with a 98% to 99% reduction in the expression of CD44 and epidermal growth factor receptor (EGFR). However, down-regulation of CK-20 in CR colon cancer cells produced no significant change in cellular growth in the absence or presence of FUOX, when compared with the corresponding controls. The current observation suggests that CDF and CDF + FUOX are highly effective in inhibiting growth and reducing colon CSCs/CSLCs in anti-miR-21-induced differentiating CR colon cancer cells and supports our contention that differentiation enhances susceptibility of CR cancer cells to conventional and nonconventional therapeutic regimen.

[1]  Bert Vogelstein,et al.  Mutational Analysis of the APC/β-Catenin/Tcf Pathway in Colorectal Cancer , 1998 .

[2]  Yves A. Lussier,et al.  Advantages of genomic complexity: bioinformatics opportunities in microRNA cancer signatures , 2011, J. Am. Medical Informatics Assoc..

[3]  Michael Dean,et al.  Tumour stem cells and drug resistance , 2005, Nature Reviews Cancer.

[4]  F. Slack,et al.  OncomiR addiction in an in vivo model of microRNA-21-induced pre-B-cell lymphoma , 2010, Nature.

[5]  Yingjie Yu,et al.  Schlafen-3 decreases cancer stem cell marker expression and autocrine/juxtacrine signaling in FOLFOX-resistant colon cancer cells. , 2011, American journal of physiology. Gastrointestinal and liver physiology.

[6]  Ying Liu,et al.  Gastrointestinal differentiation marker Cytokeratin 20 is regulated by homeobox gene CDX1 , 2009, Proceedings of the National Academy of Sciences.

[7]  Zhiwei Wang,et al.  Gemcitabine sensitivity can be induced in pancreatic cancer cells through modulation of miR-200 and miR-21 expression by curcumin or its analogue CDF. , 2010, Cancer research.

[8]  A. Rishi,et al.  Curcumin enhances the effects of 5‐fluorouracil and oxaliplatin in mediating growth inhibition of colon cancer cells by modulating EGFR and IGF‐1R , 2008, International journal of cancer.

[9]  Michael F. Clarke,et al.  Phenotypic characterization of human colorectal cancer stem cells , 2007, Proceedings of the National Academy of Sciences.

[10]  A. P. Majumdar,et al.  Curcumin targets FOLFOX-surviving colon cancer cells via inhibition of EGFRs and IGF-1R. , 2010, Anticancer research.

[11]  F. Sarkar,et al.  MicroRNA-21 induces stemness by downregulating transforming growth factor beta receptor 2 (TGFβR2) in colon cancer cells. , 2012, Carcinogenesis.

[12]  F. Sarkar,et al.  Elimination of Colon Cancer Stem-Like Cells by the Combination of Curcumin and FOLFOX. , 2009, Translational oncology.

[13]  Hans Clevers,et al.  Activation of β-Catenin-Tcf Signaling in Colon Cancer by Mutations in β-Catenin or APC , 1997, Science.

[14]  Thomas Thum,et al.  MicroRNA-21: from cancer to cardiovascular disease. , 2010, Current drug targets.

[15]  M. Noble,et al.  Cancer stem cells. , 2006, The New England journal of medicine.

[16]  G. Bommer,et al.  Wnt/Beta-Catenin/Tcf Signaling: A Critical Pathway in Gastrointestinal Tumorigenesis , 2002, Digestion.

[17]  A. P. Majumdar,et al.  Combination of dasatinib and curcumin eliminates chemo-resistant colon cancer cells , 2011, Journal of molecular signaling.

[18]  N. Colburn,et al.  MicroRNA-21 promotes cell transformation by targeting the programmed cell death 4 gene , 2008, Oncogene.

[19]  R. Plasterk,et al.  The diverse functions of microRNAs in animal development and disease. , 2006, Developmental cell.

[20]  F. Sarkar,et al.  Epidermal growth factor receptor (EGFR)–related protein inhibits multiple members of the EGFR family in colon and breast cancer cells , 2005, Molecular Cancer Therapeutics.

[21]  G. Hutvagner,et al.  A microRNA in a Multiple-Turnover RNAi Enzyme Complex , 2002, Science.

[22]  E. Miska,et al.  MicroRNA—implications for cancer , 2007, Virchows Archiv.

[23]  M. Sanders,et al.  Colon cancer stem cells: implications in carcinogenesis. , 2011, Frontiers in bioscience.

[24]  Yingjie Yu,et al.  The Wnt/β-catenin pathway regulates growth and maintenance of colonospheres , 2010, Molecular Cancer.

[25]  H. Allgayer,et al.  MicroRNA-21 (miR-21) post-transcriptionally downregulates tumor suppressor Pdcd4 and stimulates invasion, intravasation and metastasis in colorectal cancer , 2008, Oncogene.

[26]  F. Sarkar,et al.  Difluorinated-Curcumin (CDF): A Novel Curcumin Analog is a Potent Inhibitor of Colon Cancer Stem-Like Cells , 2011, Pharmaceutical Research.

[27]  H. Bidmon,et al.  Induction of Glutathione Peroxidase 4 Expression during Enterocytic Cell Differentiation* , 2011, The Journal of Biological Chemistry.